DCM
TMO icon

Driehaus Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Driehaus Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-68,294
Closed -$42.2M – 451
2024
Q3 		$42.2M Buy
68,294
+66,770
+4,381% +$39.5M 0.36% 92
2024
Q2 		$843K Buy
1,524
+653
+75% +$374K 0.01% 315
2024
Q1 		$506K Buy
871
+443
+104% +$249K 0.01% 348
2023
Q4 		$227K Buy
428
+13
+3% +$6.29K ﹤0.01% 365
2023
Q3 		$210K Buy
415
+23
+6% +$12.3K ﹤0.01% 385
2023
Q2 		$205K Sell
392
-15
-4% -$8.09K ﹤0.01% 375
2023
Q1 		$235K Sell
407
-37
-8% -$20.9K ﹤0.01% 364
2022
Q4 		$245K Sell
444
-22
-5% -$11.7K ﹤0.01% 332
2022
Q3 		$236K Sell
466
-38
-8% -$21.3K ﹤0.01% 335
2022
Q2 		$274K Buy
504
+20
+4% +$11K ﹤0.01% 330
2022
Q1 		$286K Buy
+484
New +$278K ﹤0.01% 361
2021
Q2 		– Sell
-851
Closed -$388K – 516
2021
Q1 		$388K Buy
851
+2
+0.2% +$955 0.01% 396
2020
Q4 		$395K Sell
849
-37
-4% -$17.3K 0.01% 379
2020
Q3 		$391K Buy
+886
New +$366K 0.01% 350
2019
Q4 		– Sell
-693
Closed -$202K – 575
2019
Q3 		$202K Sell
693
-109
-14% -$31.2K 0.01% 473
2019
Q2 		$236K Sell
802
-203
-20% -$55.9K 0.01% 436
2019
Q1 		$275K Buy
+1,005
New +$250K 0.01% 364
2017
Q3 		– Sell
-1,313
Closed -$229K – 600
2017
Q2 		$229K Sell
1,313
-261
-17% -$43.8K 0.01% 499
2017
Q1 		$242K Sell
1,574
-155
-9% -$23.7K 0.01% 499
2016
Q4 		$244K Buy
+1,729
New +$255K 0.01% 491

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Driehaus Capital Management's TMO Position: Q4 2024 in Review

Driehaus Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 68,294 shares — an estimated $42.2M sold.

Driehaus Capital Management first reported a position in TMO in Q4 2016 and held it in 20 quarters. The position peaked at $42.2M in Q3 2024. 2,623 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Driehaus Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 68,294 Thermo Fisher Scientific shares in Q4 2024, an estimated $42.2M.
  • Driehaus Capital Management first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 20 quarters.
  • Driehaus Capital Management's Thermo Fisher Scientific position peaked at $42.2M in Q3 2024.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.